Puma Biotechnology reported $26.08M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Array Technologies Inc ARRY:US 18.49M 3.38M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Cerulean Pharma CERU:US $ 2.24M 413.69K
Clovis Oncology CLVS:US $ 32.2M 722K
Daiichi Sankyo 4568:JP 84.5B 5.38B
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Exelixis EXEL:US $ 101.56M 3.06M
Gilead Sciences GILD:US $ 1.18B 173M
Glaxosmithkline GSK:US 2.5B 6M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Macrogenics MGNX:US $ 17.16M 1.93M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Moderna Inc MRNA:US 168M 47M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Spectrum Pharmaceuticals SPPI:US $ 12.24M 2.71M
Takeda 4502:JP 212.01B 7.83B
Tg Therapeutics TGTX:US $ 34.9M 882K
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vanda Pharmaceuticals VNDA:US $ 32.46M 4.11M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
YTE INCY:US $ 190.7M 21.84M